Browsing by Author Bertrand, Michel

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)Citation
2009The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trialsChalmers, John; MacMahon, Stephen; Ninomiya, Toshiharu; Bertrand, Michel; Boersma, Eric; Brugts, Jasper; Ferrari, Roberto; Fox, Kim; Remme, Willem; Simoons, Maarten L.; The George Institute for International Health; The George Institute for International Health; The George Institute for International HealthThe consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials, European Heart Journal (English Edition), vol.30, 11,pp 1385-1394
2010Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery diseaseChalmers, John; MacMahon, Stephen; Ninomiya, Toshiharu; Bertrand, Michel; Boersma, Eric; Brugts, Jasper; Ceconi, Claudio; Danser, A H Jan; de Maat, Moniek P M; Ferrari, Roberto; Fox, Kim; Isaacs, Aaron; Remme, Willem; Simoons, Maarten L; Uitterlinden, Andre G.; van Duijn, Cock M.; Witteman, Jacqueline; The George Institute for International Health; The George Institute for International Health; The George Institute for International HealthGenetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease, European Heart Journal (English Edition), vol.31, 15,pp 1854-1864
2014The incidence and clinical predictors of ACE-inhibitor induced dry cough by perindopril in 27,492 patients with vascular diseaseArima, Hisatomi; Chalmers, John; MacMahon, Stephen William; Bertrand, Michel; Brughts, Jasper Jan; Caliskan, K.; DiNicolantonio, James; et al, Various; Ferrari, Roberto; Fox, Kim; Mourad, Jean Jacques; Remme, Willem; Simoons, Maarten L; Zijlstra, Felix; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global HealthThe incidence and clinical predictors of ACE-inhibitor induced dry cough by perindopril in 27,492 patients with vascular disease, International Journal of Cardiology, vol.176, 3, 2014,pp 718-723
2011A Pharmacogenetic Analysis of Determinants of Hypertension and Blood Pressure Response to Angiotensin-Converting Enzyme Inhibitor Therapy in Patients With Vascular Disease and Healthy IndividualsChalmers, John; McMahon, Stephen; Ninomiya, Toshiharu; Akkerhuis, K Martin; Bertrand, Michel; Boersma, Eric; Brugts, Jasper; Cambien, Fran├žois A.; Ceconi, Claudio; Danser, A H Jan; de Maat, Moniek P M; Ferrari, Roberto; Fox, Kim; Harrap, Stephen B.; Isaacs, Aaron; Remme, Willem; Simoons, Maarten L; Uitterlinden, Andre G.; van Duijn, Cock M.; Witteman, Jacqueline; The George Institute for International Health; The George Institute for International Health; The George Institute for International HealthA Pharmacogenetic Analysis of Determinants of Hypertension and Blood Pressure Response to Angiotensin-Converting Enzyme Inhibitor Therapy in Patients With Vascular Disease and Healthy Individuals, Journal of Hypertension, vol.29, 3, 2011,pp 509-519
2017The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS TrialsChalmers, John; MacMahon, Stephen William; Bertrand, Michel; Boersma, Eric; Brugts, Jasper; Ferrari, Roberto; Fox, Keith; Remme, W.; Simoons, Maarten L.; The George Institute for Global Health; The George Institute for Global HealthThe Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials, Cardiovascular Drugs and Therapy, vol.31, 4, 2017,pp 391-400